Full Name
Dr. Jonas Paludo MD
Job Title
Assistant Professor of Medicine, Division of Hematology
Company/Affiliation
Mayo Clinic Rochester
Speaker Bio
Jonas Paludo, M.D., is an assistant professor of medicine and oncology at Mayo Clinic and the associate program director of the Hematology and Oncology Fellowship at Mayo Clinic Rochester. He graduated from Universidade Federal de Ciencias da Saude de Porto Alegre in Brazil and completed his residency in internal medicine and fellowships in hematology, oncology, and lymphoma at Mayo Clinic.
Dr. Paludo has received several honors and awards for his clinical and research excellence, including the Tow Tan Humanism in Medicine Award, the Future Leaders Award for Clinical Research in Hematology, and the 2023 Teacher of the Year Award.
Dr. Paludos research interests include the biology, genetics, and therapy of lymphoma and plasma cell disorders, the development and application of novel electronic tools and algorithms for remote monitoring of patients, and the impact of sociodemographic factors on treatment decisions and outcomes in oncology. He has published more than 80 peer-reviewed articles on topics such as Waldenstrom macroglobulinemia, mantle cell lymphoma, CAR T-cell therapy, and remote patient monitoring. He is also an editorial board member of Annals of Hematology and Oncology and a reviewer for several journals, including JAMA Oncology, Mayo Clinic Proceedings, and Blood. He is a member of professional societies such as the American Society of Clinical Oncology, the American Society of Hematology, and the Minnesota Medical Society.
Dr. Paludo has received several honors and awards for his clinical and research excellence, including the Tow Tan Humanism in Medicine Award, the Future Leaders Award for Clinical Research in Hematology, and the 2023 Teacher of the Year Award.
Dr. Paludos research interests include the biology, genetics, and therapy of lymphoma and plasma cell disorders, the development and application of novel electronic tools and algorithms for remote monitoring of patients, and the impact of sociodemographic factors on treatment decisions and outcomes in oncology. He has published more than 80 peer-reviewed articles on topics such as Waldenstrom macroglobulinemia, mantle cell lymphoma, CAR T-cell therapy, and remote patient monitoring. He is also an editorial board member of Annals of Hematology and Oncology and a reviewer for several journals, including JAMA Oncology, Mayo Clinic Proceedings, and Blood. He is a member of professional societies such as the American Society of Clinical Oncology, the American Society of Hematology, and the Minnesota Medical Society.
Speaking At
